Search

STAAR Surgical Co

Closed

SectorHealthcare

23.42 -3.26

Overview

Share price change

24h

Current

Min

23.42

Max

23.73

Key metrics

By Trading Economics

Income

5.2M

5.2M

Sales

36M

94M

EPS

0.29

Profit margin

5.567

Employees

921

EBITDA

19M

10M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+34% upside

Dividends

By Acuity

Next Earnings

12 sie 2026

Market Stats

By TradingEconomics

Market Cap

-192M

1.2B

Previous open

26.68

Previous close

23.42

News Sentiment

By Acuity

53%

47%

268 / 340 Ranking in Healthcare

STAAR Surgical Co Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

22 lip 2026, 18:11 UTC

News

Wedbush reiterated its OUTPERFORM rating on STAAR Surgical, maintaining a $40 price target, contributing to shares trading higher today.

21 lip 2026, 16:56 UTC

Social Media

STAAR Surgical preannounces second-quarter revenue over $90 million, up from $44.3 million last year, as shares gain amid market volatility.

20 lip 2026, 20:01 UTC

News

STAAR Surgical shares are lower amid investor concerns over sustainability despite projected Q2 sales exceeding $90 million and strong growth in China and the Americas.

Peer Comparison

Price change

STAAR Surgical Co Forecast

Price Target

By TipRanks

34% upside

12 Months Forecast

Average 31.33 USD  34%

High 40 USD

Low 25 USD

Based on 8 Wall Street analysts offering 12 month price targets forSTAAR Surgical Co - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

8 ratings

2

Buy

6

Hold

0

Sell

Sentiment

By Acuity

268 / 340 Ranking in Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
help-icon Live chat